Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBI112 in Moderate-to-Severe Plaque Psoriasis (Phase II)
CTR20212021Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Aug 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of picankibart in plaque psoriasis, psoriatic arthritis (PsA), psoriasis, nail psoriasis, sponsored by Innovent Biologics. Started Aug 2021; status: completed.
02
Drugs
picankibart
03
Conditions
plaque psoriasispsoriatic arthritis (PsA)psoriasisnail psoriasis
Beyond the preview
Go deeper on CTR20212021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212021.